To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension

NCT01403922 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

80

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's decision to terminate

Conditions

Chronic Hypertension

Interventions

DRUG: TC-5214
DRUG: TC-5214

Sponsor

AstraZeneca